Ensign Peak Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-718,682
| Closed | -$48.4M | – | 1726 |
|
|
2023
Q4 | $48.4M | Sell |
718,682
-1,865,991
| -72% | -$126M | 0.1% | 190 |
|
|
2023
Q3 | $175M | Buy |
2,584,673
+90,818
| +4% | +$6.15M | 0.37% | 62 |
|
|
2023
Q2 | $178M | Buy |
2,493,855
+145,938
| +6% | +$10.4M | 0.36% | 62 |
|
|
2023
Q1 | $163M | Buy |
2,347,917
+218,959
| +10% | +$15.2M | 0.35% | 73 |
|
|
2022
Q4 | $144M | Buy |
2,128,958
+20,454
| +1% | +$1.39M | 0.33% | 79 |
|
|
2022
Q3 | $116M | Sell |
2,108,504
-555,988
| -21% | -$30.5M | 0.29% | 82 |
|
|
2022
Q2 | $176M | Buy |
2,664,492
+266,155
| +11% | +$17.6M | 0.42% | 60 |
|
|
2022
Q1 | $159M | Buy |
2,398,337
+1,541,513
| +180% | +$102M | 0.32% | 71 |
|
|
2021
Q4 | $49.9M | Buy |
856,824
+686,697
| +404% | +$40M | 0.1% | 186 |
|
|
2021
Q3 | $10.2M | Buy |
170,127
+5,417
| +3% | +$325K | 0.02% | 427 |
|
|
2021
Q2 | $9.87M | Buy |
164,710
+17
| +0% | +$1.02K | 0.02% | 430 |
|
|
2021
Q1 | $8.19M | Sell |
164,693
-10,281
| -6% | -$511K | 0.02% | 474 |
|
|
2020
Q4 | $8.75M | Buy |
+174,974
| New | +$8.75M | 0.02% | 448 |
|
|
2020
Q3 | – | Sell |
-185,065
| Closed | -$9.79M | – | 1745 |
|
|
2020
Q2 | $9.79M | Buy |
185,065
+172,485
| +1,371% | +$9.12M | 0.03% | 431 |
|
|
2020
Q1 | $562K | Sell |
12,580
-44,267
| -78% | -$1.98M | ﹤0.01% | 1362 |
|
|
2019
Q4 | $2.83M | Buy |
+56,847
| New | +$2.83M | 0.01% | 883 |
|